58
Views
5
CrossRef citations to date
0
Altmetric
Original Research

AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis

, , , , &
Pages 441-449 | Published online: 09 Sep 2015

Figures & data

Table 1 Prevalence of CD

Table 2 Market share and absolute number of patients receiving BoNT-A

Table 3 BoNT-A medication treatment cost and dosage

Table 4 Resource use for BoNT-A and best supportive care (without BoNT-A) arms in the base case

Table 5 BoNT-A medication dosage for “real-world” settings

Table 6 Net 5-year budget impact of increasing abobotulinumtoxinA market share compared to status quo assumptions in the treatment of cervical dystonia in the UK

Figure 1 Cost of BoNT-A and best supportive care per patient per year by cost component.

Abbreviation: BoNT-A, botulinum neurotoxin A.
Figure 1 Cost of BoNT-A and best supportive care per patient per year by cost component.

Figure 2 Tornado diagram of one-way sensitivity analysis showing the parameters that are most influential on net budget impact.

Figure 2 Tornado diagram of one-way sensitivity analysis showing the parameters that are most influential on net budget impact.

Table 7 Variable description for tornado diagram